{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:15:33Z","timestamp":1788909333876,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Islet Research and Training Network and NSERC-CREATE program","award":["MSc training award"],"award-info":[{"award-number":["MSc training award"]}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["3-COE-2022-1103-M-B"],"award-info":[{"award-number":["3-COE-2022-1103-M-B"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["PJT-479641"],"award-info":[{"award-number":["PJT-479641"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["PJT-485915"],"award-info":[{"award-number":["PJT-485915"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["TDP-186359"],"award-info":[{"award-number":["TDP-186359"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Foundation for Innovation John R. Evans Leaders Fund","award":["43168"],"award-info":[{"award-number":["43168"]}]},{"DOI":"10.13039\/100008795","name":"Manitoba Medical Service Foundation","doi-asserted-by":"publisher","award":["2023 Allen Rouse Basic Science Career Development"],"award-info":[{"award-number":["2023 Allen Rouse Basic Science Career Development"]}],"id":[{"id":"10.13039\/100008795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Institutes of Health Research and Breakthrough T1D","award":["197485"],"award-info":[{"award-number":["197485"]}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","award":["OG-3-22-5694-PT"],"award-info":[{"award-number":["OG-3-22-5694-PT"]}],"id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Breakthrough T1D Advanced Postdoctoral Fellowship","award":["3-APF-2022\u20131141-A-N"],"award-info":[{"award-number":["3-APF-2022\u20131141-A-N"]}]},{"name":"Canadian Islet Research and Training Network and Breakthrough T1D","award":["postdoctoral fellowship award"],"award-info":[{"award-number":["postdoctoral fellowship award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00125-025-06603-3","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:45:17Z","timestamp":1763019917000},"page":"421-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5802-1560","authenticated-orcid":false,"given":"Camille","family":"Pr\u00e9fontaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9936-8386","authenticated-orcid":false,"given":"Jasmine","family":"Pipella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-4668","authenticated-orcid":false,"given":"Nayara","family":"Rampazzo Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-0383","authenticated-orcid":false,"given":"Yi-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0586","authenticated-orcid":false,"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6851-8899","authenticated-orcid":false,"given":"Peter J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"6603_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2020","unstructured":"Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A (2020) Type 1 diabetes mellitus as a disease of the \u03b2- cell (do not blame the immune system?). Nat Rev Endocrinol 17(3):150\u2013161. https:\/\/doi.org\/10.1038\/s41574-020-00443-4","journal-title":"Nat Rev Endocrinol"},{"key":"6603_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.trsl.2019.08.001","volume":"213","author":"EK Sims","year":"2019","unstructured":"Sims EK, Syed F, Nyalwidhe J et al (2019) Abnormalities in proinsulin processing in islets from individuals with longstanding T1D. Transl Res 213:90\u201399. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.001","journal-title":"Transl Res"},{"issue":"5","key":"6603_CR3","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2337\/db16-1343","volume":"66","author":"T Rodriguez-Calvo","year":"2017","unstructured":"Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of \u03b2-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334\u20131345. https:\/\/doi.org\/10.2337\/db16-1343","journal-title":"Diabetes"},{"issue":"2","key":"6603_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dc17-2625","volume":"42","author":"EK Sims","year":"2019","unstructured":"Sims EK, Bahnson HT, Nyalwidhe J et al (2019) Proinsulin secretion is a persistent feature of type 1 diabetes. Diabetes Care 42(2):258\u2013264. https:\/\/doi.org\/10.2337\/dc17-2625","journal-title":"Diabetes Care"},{"issue":"12","key":"6603_CR5","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00125-024-06275-5","volume":"67","author":"PS Apaolaza","year":"2024","unstructured":"Apaolaza PS, Chen Y-C, Grewal K et al (2024) Quantitative analysis of islet prohormone convertase 1\/3 expression in human pancreas donors with diabetes. Diabetologia 67(12):2771\u20132785. https:\/\/doi.org\/10.1007\/s00125-024-06275-5","journal-title":"Diabetologia"},{"issue":"3","key":"6603_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cmet.2017.08.013","volume":"26","author":"C Wasserfall","year":"2017","unstructured":"Wasserfall C, Nick HS, Campbell-Thompson M et al (2017) Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab 26(3):568-575.e3. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.013","journal-title":"Cell Metab"},{"issue":"11","key":"6603_CR7","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-023-05970-z","volume":"66","author":"PJ Thompson","year":"2023","unstructured":"Thompson PJ, Pipella J, Rutter GA, Gaisano HY, Santamaria P (2023) Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell. Diabetologia 66(11):1971\u20131982. https:\/\/doi.org\/10.1007\/s00125-023-05970-z","journal-title":"Diabetologia"},{"issue":"2","key":"6603_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco R, Krizhanovsky V, Baker D, d\u2019Adda di Fagagna F, d\u2019Adda di Fagagna F (2021) Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol 22(2):75\u201395. https:\/\/doi.org\/10.1038\/s41580-020-00314-w","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6603_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2017.02.002","volume":"80","author":"A Lombardi","year":"2017","unstructured":"Lombardi A, Tomer Y (2017) Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress. J Autoimmun 80:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2017.02.002","journal-title":"J Autoimmun"},{"issue":"11","key":"6603_CR10","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2337\/db17-1006","volume":"67","author":"E Horwitz","year":"2018","unstructured":"Horwitz E, Krogvold L, Zhitomirsky S et al (2018) Beta cell DNA damage response promotes islet inflammation in type 1 diabetes. Diabetes 67(11):2305\u201311. https:\/\/doi.org\/10.2337\/db17-1006","journal-title":"Diabetes"},{"issue":"5","key":"6603_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","volume":"29","author":"PJ Thompson","year":"2019","unstructured":"Thompson PJ, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A (2019) Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab 29(5):1045\u201360. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.021","journal-title":"Cell Metab"},{"key":"6603_CR12","doi-asserted-by":"publisher","first-page":"101524","DOI":"10.1016\/j.molmet.2022.101524","volume":"62","author":"G Brawerman","year":"2022","unstructured":"Brawerman G, Pipella J, Thompson PJ (2022) DNA damage to \u03b2 cells in culture recapitulates features of senescent \u03b2 cells that accumulate in Type 1 Diabetes. Mol Metab 62:101524. https:\/\/doi.org\/10.1016\/j.molmet.2022.101524","journal-title":"Mol Metab"},{"key":"6603_CR13","doi-asserted-by":"publisher","first-page":"1212716","DOI":"10.3389\/fendo.2023.1212716","volume":"14","author":"J Cha","year":"2023","unstructured":"Cha J, Aguayo-Mazzucato C, Thompson PJ (2023) Pancreatic \u03b2-cell senescence in diabetes: mechanisms, markers and therapies. Front Endocrinol (Lausanne) 14:1212716. https:\/\/doi.org\/10.3389\/fendo.2023.1212716","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6603_CR14","doi-asserted-by":"publisher","unstructured":"Rampazzo Morelli N, Pipella J, Thompson PJ (2024) Establishing evidence for immune surveillance of \u03b2-cell senescence. Trends Endocrinol Metab Feb 2:S1043-2760(24)00017\u20131. https:\/\/doi.org\/10.1016\/j.tem.2024.01.003","DOI":"10.1016\/j.tem.2024.01.003"},{"issue":"July","key":"6603_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2023.101772","volume":"76","author":"B Blanchi","year":"2023","unstructured":"Blanchi B, Taurand M, Colace C et al (2023) EndoC-bH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol Metab 76(July):1\u201312. https:\/\/doi.org\/10.1016\/j.molmet.2023.101772","journal-title":"Mol Metab"},{"issue":"1","key":"6603_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cmet.2024.09.001","volume":"37","author":"JD Ewald","year":"2025","unstructured":"Ewald JD, Lu Y, Ellis CE et al (2025) HumanIslets.com: Improving accessibility, integration, and usability of human research islet data. Cell Metab 37(1):7\u201311. https:\/\/doi.org\/10.1016\/j.cmet.2024.09.001","journal-title":"Cell Metab"},{"issue":"7","key":"6603_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2337\/db19-0058","volume":"68","author":"KH Kaestner","year":"2019","unstructured":"Kaestner KH, Powers AC, Naji A, Atkinson MA (2019) NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the Human Pancreas Analysis Program (HPAP). Diabetes 68(7):1394\u20131402. https:\/\/doi.org\/10.2337\/db19-0058","journal-title":"Diabetes"},{"issue":"2","key":"6603_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","volume":"4","author":"M Fasolino","year":"2022","unstructured":"Fasolino M, Schwartz GW, Patil AR et al (2022) Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes. Nat Metab 4(2):284\u2013299. https:\/\/doi.org\/10.1038\/s42255-022-00531-x","journal-title":"Nat Metab"},{"key":"6603_CR19","doi-asserted-by":"publisher","first-page":"932516","DOI":"10.3389\/fendo.2022.932516","volume":"13","author":"G Brawerman","year":"2022","unstructured":"Brawerman G, Ntranos V, Thompson PJ (2022) Alpha cell dysfunction in type 1 diabetes is independent of a senescence program. Front Endocrinol (Lausanne) 13:932516. https:\/\/doi.org\/10.3389\/fendo.2022.932516","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"6603_CR20","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1152\/ajpendo.00257.2024","volume":"327","author":"N Rampazzo Morelli","year":"2024","unstructured":"Rampazzo Morelli N, Pr\u00e9fontaine C, Pipella J, Thompson PJ (2024) Secreted GDF15 maintains transcriptional responses during DNA damage-mediated senescence in human beta cells. Am J Physiol Endocrinol Metab 327(4):E552\u2013E562. https:\/\/doi.org\/10.1152\/ajpendo.00257.2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"6603_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cmet.2018.10.007","volume":"29","author":"DC Saunders","year":"2019","unstructured":"Saunders DC, Brissova M, Phillips N et al (2019) Ectonucleoside triphosphate diphosphohydrolase-3 antibody targets adult human pancreatic \u03b2 cells for in vitro and in vivo analysis. Cell Metab 29(3):745-754.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.007","journal-title":"Cell Metab"},{"issue":"1","key":"6603_CR22","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.xpro.2024.102923","volume":"5","author":"H Lee","year":"2024","unstructured":"Lee H, Thompson PJ, Engin F (2024) Protocol for quantifying SA-\u03b2-gal activity as a measure of senescence in islets of a mouse model of type 1 diabetes. STAR Protoc 5(1):102923. https:\/\/doi.org\/10.1016\/j.xpro.2024.102923","journal-title":"STAR Protoc"},{"key":"6603_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s42255-023-00806-x","volume":"5","author":"AR Patil","year":"2023","unstructured":"Patil AR, Schug J, Naji A, Kaestner KH, Faryabi RB, Vahedi G (2023) Single-cell expression profiling of islets generated by the Human Pancreas Analysis Program. Nat Metab 5:713\u2013715. https:\/\/doi.org\/10.1038\/s42255-023-00806-x","journal-title":"Nat Metab"},{"issue":"4","key":"6603_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cmet.2012.08.010","volume":"16","author":"I Mor\u00e1n","year":"2012","unstructured":"Mor\u00e1n I, Akerman I, van de Bunt M et al (2012) Human \u03b2 cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 16(4):435\u2013448. https:\/\/doi.org\/10.1016\/j.cmet.2012.08.010","journal-title":"Cell Metab"},{"issue":"7","key":"6603_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.cmet.2024.06.001","volume":"36","author":"J Kolic","year":"2024","unstructured":"Kolic J, Sun WG, Cen HH et al (2024) Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease. Cell Metab 36(7):1619-1633.e5. https:\/\/doi.org\/10.1016\/j.cmet.2024.06.001","journal-title":"Cell Metab"},{"issue":"19","key":"6603_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20194776","volume":"20","author":"PJ Thompson","year":"2019","unstructured":"Thompson PJ, Shah A, Apostolopolou H, Bhushan A (2019) BET proteins are required for transcriptional activation of the senescent islet cell secretome in type 1 diabetes. Int J Mol Sci 20(19):1\u201313. https:\/\/doi.org\/10.3390\/ijms20194776","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6603_CR27","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.cmet.2023.10.014","volume":"35","author":"H Lee","year":"2023","unstructured":"Lee H, Sahin GS, Chen C et al (2023) Stress-induced b cell early senescence confers protection against type 1 diabetes. Cell Metab 35(12):2200\u20132215. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.014","journal-title":"Cell Metab"},{"issue":"4","key":"6603_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nm.4054","volume":"22","author":"A Helman","year":"2016","unstructured":"Helman A, Klochendler A, Azazmeh N et al (2016) p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion. Nat Med 22(4):412\u201320. https:\/\/doi.org\/10.1038\/nm.4054","journal-title":"Nat Med"},{"issue":"11","key":"6603_CR29","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1093\/nar\/gkae313","volume":"53","author":"M Patra","year":"2024","unstructured":"Patra M, Klochendler A, Condiotti R et al (2024) Senescence of human pancreatic beta cells enhances functional maturation through chromatin reorganization and promotes interferon responsiveness. Nucleic Acids Res 53(11):6298\u20136316. https:\/\/doi.org\/10.1093\/nar\/gkae313","journal-title":"Nucleic Acids Res"},{"issue":"September","key":"6603_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/dom.12719","volume":"18","author":"A Helman","year":"2016","unstructured":"Helman A, Avrahami D, Klochendler A et al (2016) Effects of ageing and senescence on pancreatic \u03b2-cell function. Diabetes, Obes Metab 18(September):58\u201362. https:\/\/doi.org\/10.1111\/dom.12719","journal-title":"Diabetes, Obes Metab"},{"issue":"12","key":"6603_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.molmet.2015.09.008","volume":"4","author":"M Benazra","year":"2015","unstructured":"Benazra M, Lecomte M-J, Colace C et al (2015) A human beta cell line with drug inducible excision of immortalizing transgenes. Mol Metab 4(12):916\u2013925. https:\/\/doi.org\/10.1016\/j.molmet.2015.09.008","journal-title":"Mol Metab"},{"issue":"8","key":"6603_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.dnarep.2013.04.015","volume":"12","author":"T Iyama","year":"2013","unstructured":"Iyama T, Wilson DM (2013) DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 12(8):620\u2013636. https:\/\/doi.org\/10.1016\/j.dnarep.2013.04.015","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"6603_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2337\/db09-0792.O.T","volume":"59","author":"O Tavana","year":"2010","unstructured":"Tavana O, Puebla-osorio N, Sang M, Zhu C (2010) Absence of p53-dependent apoptosis combined with Nonhomologous End-Joining Deficiency Leads to a Severe Diabetic Phenotype in Mice. Diabetes 59(1):135\u201342. https:\/\/doi.org\/10.2337\/db09-0792.O.T","journal-title":"Diabetes"},{"issue":"5","key":"6603_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/ng.3531","volume":"48","author":"J Dooley","year":"2016","unstructured":"Dooley J, Tian L, Schonefeldt S et al (2016) Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes. Nat Genet 48(5):519\u2013527. https:\/\/doi.org\/10.1038\/ng.3531","journal-title":"Nat Genet"},{"issue":"40","key":"6603_CR35","doi-asserted-by":"publisher","first-page":"eabo3932","DOI":"10.1126\/sciadv.abo3932","volume":"8","author":"S Shrestha","year":"2022","unstructured":"Shrestha S, Erikson G, Lyon J et al (2022) Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. Sci Adv 8(40):eabo3932. https:\/\/doi.org\/10.1126\/sciadv.abo3932","journal-title":"Sci Adv"},{"issue":"10","key":"6603_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1369\/00221554221138368","volume":"70","author":"G Teitelman","year":"2022","unstructured":"Teitelman G (2022) Abnormal expression of an insulin synthesizing enzyme in islets of adult autoantibody positive donors. J Histochem Cytochem 70(10):695\u2013706. https:\/\/doi.org\/10.1369\/00221554221138368","journal-title":"J Histochem Cytochem"},{"issue":"April","key":"6603_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.667989","volume":"12","author":"T Rodriguez-Calvo","year":"2021","unstructured":"Rodriguez-Calvo T, Johnson JD, Overbergh L, Dunne JL (2021) Neoepitopes in type 1 diabetes: etiological insights, biomarkers and therapeutic targets. Front Immunol 12(April):1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2021.667989","journal-title":"Front Immunol"},{"issue":"February","key":"6603_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.624590","volume":"11","author":"JD Piganelli","year":"2021","unstructured":"Piganelli JD, Mamula MJ, James EA (2021) The role of \u03b2 cell stress and neo-epitopes in the immunopathology of type 1 diabetes. Front Endocrinol (Lausanne) 11(February):1\u201310. https:\/\/doi.org\/10.3389\/fendo.2020.624590","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6603_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41467-025-55908-9","volume":"16","author":"A Carr\u00e9","year":"2025","unstructured":"Carr\u00e9 A, Samassa F, Zhou Z et al (2025) Interferon-\u03b1 promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic \u03b2-cells. Nat Commun 16(1):765. https:\/\/doi.org\/10.1038\/s41467-025-55908-9","journal-title":"Nat Commun"},{"issue":"6","key":"6603_CR40","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","volume":"28","author":"S Gonzalez-Duque","year":"2018","unstructured":"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating na\u00efve CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960.e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.007","journal-title":"Cell Metab"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06603-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:02:59Z","timestamp":1767823379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6603"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06603-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank the organ donors and their families. We thank the Network for Pancreatic Organ Donors (nPOD) (University of Florida, USA) for fixed pancreatic tissue sample procurement and distribution. We also thank the Alberta Diabetes Institute IsletCore for providing human islets for research with the assistance of the Human Organ Procurement and Exchange (HOPE) program, Trillium Gift of Life Network (TGLN) and other Canadian organ procurement organisations. The authors thank the NIDDK-funded Integrated Islet Distribution Program (IIDP) (RRID:SCR _014387) at City of Hope, NIH grant no. U24DK098085 and the Breakthrough T1D (formerly JDRF)-funded IIDP Islet Award Initiative for providing human islets for research for this study. This manuscript used data acquired from the database (\n                      \n                      ) of the Human Pancreas Analysis Program (HPAP; RRID:SCR_016202; PMID: 31127054; PMID: 36206763). HPAP is part of a Human Islet Research Network (RRID:SCR_014393) consortium (UC4-DK112217, U01-DK123594, UC4-DK112232 and U01-DK123716). This work also includes data and\/or analyses from HumanIslets.com funded by the Canadian Institutes of Health Research, Breakthrough T1D Canada, and Diabetes Canada (5-SRA-2021-1149-S-B\/TG 179092) with data from islets isolated by the Alberta Diabetes Institute IsletCore with the support of the Human Organ Procurement and Exchange program, Trillium Gift of Life Network, BC Transplant, Quebec Transplant and other Canadian organ procurement organisations with written informed donor consent as approved by the Human Research Ethics Board at the University of Alberta (Pro00013094). The graphical abstract was created in BioRender.com.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"All data related to the manuscript are included in the text or in the\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"CP was supported by a Canadian Islet Research Network NSERC-CREATE MSc studentship award. JP was supported by a PhD studentship in Health Research from Research Manitoba. NRM was supported by a Canadian Islet Research Network-Breakthrough T1D postdoctoral fellowship award. CBV was supported by grants from the Canadian Institutes of Health Research and Breakthrough T1D (TDP-186359; 3-COE-2022-1103-M-B). Y-CC was supported by an Advanced Post-doctoral Fellowship from Breakthrough T1D (3-APF-2022\u20131141-A-N) and a Research Excellence, Diversity, and Independence (REDI) Early Career Transition Award from the Canadian Institutes of Health Research and Breakthrough T1D (197485). The laboratory of PJT was supported by a Diabetes Canada End Diabetes 2022 grant (OG-3-22-5694-PT), grants from the Canadian Institutes of Health Research (PJT-479641 and PJT-485915) and Breakthrough T1D Canada (4-SRA-2023-1184-S-N), the 2023 Allen Rouse Basic Science Career Award from the Manitoba Medical Services Foundation and the Canada Foundation for Innovation John Evan Leaders Fund award (43168).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"CBV receives a salary award from the BC Children\u2019s Hospital Research Institute. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"CP, JP, NRM and PJT designed the experiments. CP, JP, NRM and YCC performed the experiments with input and guidance from PJT. CBV, PJT and CP wrote the manuscript with editing by JP, NRM, YCC and CBV. All authors approved the final manuscript for submission. PJT is the guarantor of this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}